One specific example is using the inhibitor KH‐3 to disrupt the interaction of the RNA‐binding protein Hu antigen R (HuR) and FOXQ1 (Forkhead Box Q1) mRNA, leading to inhibition of breast cancer invasion in high‐grade tumors with poor clinical outcome (X. Wu et al., 2020). This evidence concerns the gene FOXQ1 and breast carcinoma.